U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06860620) titled 'Efficacy of Zinc Supplementation in Maintaining Sustained Remission in Children With Steroid-sensitive Nephrotic Syndrome' on Feb. 28.
Brief Summary: This study aims to fill the gaps by determining the efficacy of zinc supplementation in maintaining sustained remission in children with steroid sensitive nephrotic syndrome (SSNS).
Study Start Date: Jan. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Steroid-Sensitive Nephrotic Syndrome
Intervention:
DRUG: Zinc supplementation plus standard treatment
children were given 5 mg of elemental zinc sulfate as a single daily dose for children less than 4 years of age and 10 mg for chi...